Filing Details

Accession Number:
0000950170-24-106413
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-13 16:47:50
Reporting Period:
2024-09-11
Accepted Time:
2024-09-13 16:47:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1719714 Mereo Biopharma Group Plc MREO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2005875 Alexandra Hughes-Wilson C/O Mereo Biopharma Group Plc
4Th Floor, One Cavendish Place
London X0 W1G 0QF
See Remarks No No No No
Transaction Summary
Number of Shares After Transactions: 242,881 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Representing Ordinary Shares Acquisiton 2024-09-11 40,000 $0.00 74,548 No 4 M Direct
American Depositary Shares Representing Ordinary Shares Acquisiton 2024-09-11 93,333 $1.40 167,881 No 4 M Direct
American Depositary Shares Representing Ordinary Shares Acquisiton 2024-09-11 75,000 $1.01 242,881 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
American Depository Shares Performance Based Restricted Stock Unit Disposition 2024-09-11 40,000 $0.00 40,000 $0.00
American Depository Shares Share Options (Right to buy) Disposition 2024-09-11 93,333 $1.40 93,333 $1.40
American Depository Shares Share Options (Right to buy) Disposition 2024-09-11 75,000 $1.01 75,000 $1.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-09-11 2025-01-25 No 4 M Direct
0 2032-01-14 No 4 M Direct
0 2033-01-25 No 4 M Direct
Footnotes
  1. Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
  2. Represents performance-based restricted stock unit earned under the issuer's 2019 Employee Incentive Plan (the "Plan"), that vested on September 11, 2024 based on satisfaction of ADS price threshold values over a two year performance period.
  3. 160,000 options were issued on 01/14/2022 and 25% of the shares underlying this award became exercisable on January 14, 2023, with the remainder vesting in equal monthly installments thereafter.
  4. 240,000 options were issued on 01/25/2023 and 25% of the shares underlying this award became exercisable on January 25, 2024, with the remainder vesting in equal monthly installments thereafter.